Stryker Corporation

While Stryker is a global medical tech company focused on expanding its presence across international markets, the US makes up ~68% of its total revenues.

Stryker is a leading medical technology company and subject to big challenges impacting the medical technology industry, both systematic and unsystematic.

Stryker’s Neurotechnology and Spine segment reported an increase of 5% in net sales in 2014, driven by increased demand for neurotechnology products.

Stryker offers a diversified portfolio of more than 60,000 products and services, with a focus on quality outcomes at lower costs through collaborations.

Becton, Dickinson and Company is one of the five biggest medical device companies in the United States.

As it is susceptible to industry risks, Becton, Dickinson and Company (BDX), or BD, is transforming its business model.

Though the medical device sector displays significant resilience towards changes in the economic environment, economic factors do impact short-term demand substantially.

The US medical device industry has rebounded sharply since its 2008 decline, and it is trading at a high PE of 21.9x.

Medical device manufacturers source various medical components and parts from suppliers in order to assemble or develop medical devices.

Medtronic’s Restorative Therapies Group’s net sales in fiscal 2015 reached ~$6.8 billion, which represents an increase of 4% over the prior fiscal year.

Headquartered in Minnesota, Medtronic is the world’s largest pure-play medical device company, with operations in 160 countries and over 85,000 employees.

The US medical device industry has been working on traditional business models based on R&D and innovation where physicians have been the target audience.

The US medical devices industry can be categorized according to the field of medicine in which a device is used.

Over a period of 128 years, Johnson & Johnson (JNJ) diversified its business into three business segments.

The Medical Devices and Diagnostics segment contributes over 37% of Johnson & Johnson’s revenue. In 2014, the segment generated about $27.5 billion in revenue.

Espicom Business Intelligence forecasts the Israeli market to be valued at $1.096 billion in 2016—a 20% increase over five years. The country looks to the medical device industry for a significant amount of growth.